Chemical components from (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity.
Fuente:
PubMed
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Sprache: | en |
| Veröffentlicht: |
Natural product research
2026
|
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1868266046407835649 |
|---|---|
| author | Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li |
| author_facet | Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li |
| collection | PubMed - marine biology |
| contents | Chemical components from (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li The endangered (W.Hunter) Roxb. () remains largely unexplored in chemical constituents and bioactivities. Therefore, fifteen compounds (-), comprising monoterpene indole alkaloids, lignans, flavonoids, triterpenoids, coumarins, and fatty acids, were isolated from this species. Their inhibitory effects against cell division cycle 25B (CDC25B) phosphatase and vasodilatory activities were then evaluated. Results showed that compound (strictosamide) exhibited a notable inhibitory effect on CDC25B phosphatase, with the IC value of 5.4 μM, comparable to the positive control (NaVO). Compound (3dihydrocadambine) effectively revealed strong vasodilatory activity with EC values of 2.4 μM and 2.1 μM, respectively, similar levels comparable to the positive control (verapamil). Interestingly, these activities of compounds and were evaluated for the first time in this work. Moreover, network pharmacology and molecular docking predicted compound to correlate with the p53-Hippo-TGF- antitumor signalling pathway and compound with the cAMP/cGMP-PKG cardiovascular signalling pathway. This work provides preliminary experimental data for the development of potential lead compounds from . |
| format | Artículo científico |
| id | pubmed_42176307 |
| institution | PubMed |
| language | en |
| publishDate | 2026 |
| publisher | Natural product research |
| record_format | pubmed |
| spellingShingle | Chemical components from (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li Chemical components from (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. Liu, Wenyan Jin, Song Wang, Ziming Li, Xinyue Li, Zheng Xu, Yanqi Wang, Wei Wu, Yanchao Huang, Li The endangered (W.Hunter) Roxb. () remains largely unexplored in chemical constituents and bioactivities. Therefore, fifteen compounds (-), comprising monoterpene indole alkaloids, lignans, flavonoids, triterpenoids, coumarins, and fatty acids, were isolated from this species. Their inhibitory effects against cell division cycle 25B (CDC25B) phosphatase and vasodilatory activities were then evaluated. Results showed that compound (strictosamide) exhibited a notable inhibitory effect on CDC25B phosphatase, with the IC value of 5.4 μM, comparable to the positive control (NaVO). Compound (3dihydrocadambine) effectively revealed strong vasodilatory activity with EC values of 2.4 μM and 2.1 μM, respectively, similar levels comparable to the positive control (verapamil). Interestingly, these activities of compounds and were evaluated for the first time in this work. Moreover, network pharmacology and molecular docking predicted compound to correlate with the p53-Hippo-TGF- antitumor signalling pathway and compound with the cAMP/cGMP-PKG cardiovascular signalling pathway. This work provides preliminary experimental data for the development of potential lead compounds from . |
| title | Chemical components from (W.Hunter) Roxb. and their preliminary bioactivities in CDC25B phosphatase inhibition and vasodilatory activity. |
| url | https://pubmed.ncbi.nlm.nih.gov/42176307/ |